ProBioGen’s GlymaxX® ADCC Enhancement Technology used by Betta Pharmaceuticals
Bispecific Antibody for Cancer Treatment Optimized by GlymaxX® Technology
3 Min
More 
Pre-call Announcement
“Multinational research projects on Personalised Medicine for Neurodegenerative Diseases”
2 Min
More Charité leads on three new EU-funded projects
More than €10 million in funding awarded to Charité
4 Min
More Berlin partners and the University of Oxford consolidate their cooperation
The research partnership between the University of Oxford and the four Berlin partners – Freie Universität Berlin, Humboldt-Universität zu Berlin, Technische Universität Berlin, and Charité – Universitätsmedizin Berlin – is picking up speed: all five…
1 Min
More NOXXON announces key findings that NOX-A12 plus Keytruda® induces an immune response and results in clinical benefit for patients
Findings include stable disease and prolonged time on treatment vs. prior therapy in heavily pretreated metastatic pancreatic and colorectal cancer patients
2 Min
More How dietary fiber and gut bacteria protect the cardiovascular system
The fatty acid propionate helps defend against the effects of high blood pressure, including atherosclerosis and heart tissue remodeling, a study on mice has found. Gut bacteria produce the substance – which calms the immune cells that drive up blood…
3 Min
More Prostate cancer – New computer model enables researchers to predict course of disease
How does a normal cell turn into a deadly cancer? Seeking an answer to this question, and working alongside other international working groups, researchers from Charité – Universitätsmedizin Berlin examined the tumor genomes of nearly 300 prostate…
2 Min
More ERC Synergy Grant awarded to project exploring playful learning
Implementing a project entitled ‘BrainPlay’, an interdisciplinary team of researchers will explore the way in which play affects the human brain. Researchers from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH),…
1 Min
More Are we immune to the CRISPR-Cas9 gene editing scissors?
The CRISPR-Cas9 gene editing system has been generating excitement within the field of gene therapy, inspiring hopes of molecular tools capable of treating genetic diseases. By studying immune responses to CRISPR-Cas9 in humans, researchers from…
3 Min
More Clariness today announced it has acquired Viomedo, a leading online platform for clinical trials and provider of patient enrollment services
Over the last 13 years, Clariness has built a patient recruitment business covering 45 countries and 8 of
the top 10 pharmaceutical companies. “Clinical trials face increasing challenges in terms of cost and
timelines. Clariness strives to drive…
1 Min
More Show more items
